2,460
Views
59
CrossRef citations to date
0
Altmetric
Research Article

Hyperthermia in oncology

Pages 1-18 | Published online: 09 Jul 2009

References

  • AMICHETTI, M., GRIAFF, C., FFI I IN, G., PANI, G., BOLNER, A., MALUTA, S., and VALDAGNI, R., 1993, Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: a phase I-II study. International Journal of Radiation Oncology, Biology and Physics, 26, 801–807.
  • BEDWINEK, J. M., LEE, J., FINEBERG, B., and OCWIEZA, M., 1981, Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer, 47, 2232–2235.
  • BORNSTEIN, B. A., ZOURANJIAN, P. S., HANSEN, J. L., FRASER, S. M., GELWAN, L. A., TEICHER, B. A., and SVENSSON, G. K., 1992, Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinoma. International Journal of Radiation Oncology, Biology and Physics, 25, 79–85.
  • CARTER, D. L., MACFALL, J. R., CLEGG, S. T., WAN, X., PRESCOTT, D. M., CHARLES, H. C., and SAMULSKI, T. V., 1998, Magnetic resonance thermometry during hyperthermia for human high-grade sarcoma. International Journal of Radiation Oncology, Biology and Physics, 40, 815–822.
  • DATTA, N. R., BOSE, A. K KAPOOR, H. K., and GUPTA S., 1990, Head and neck cancers: results of thermoradiotherapy versus radiotherapy. International Journal of Hyperthermia, 6, 479–486.
  • DEWEY, W. C., 1994, Arrhenius relationships from the molecule and cell to the clinic. International Journal of Hyperthermia, 10, 457–483.
  • DINGES, S., HARDER, C., WURM, R., BUCHALI, A., BLOHMER, J., GELLERMANN, J., WUST, P., RANDOW, H., and BUDACH, V., 1998, Combined treatment of inoperable carcinomas of the uterine cervix with radiotherapy and regional hyperthermia. Results of a phase II trial. Strahlentherapie und Onkologie, 174, 517–521.
  • EGGERMONT, A. M. M., KOOPS, H., LINARD, D., KROON, B. B. R., VAN GFFI, A., HOEKSTRA, H. J., and LEIEUNE, F. J., 1996, Isolated limb perfusion with high-dose tumor necrosis factor-a in combination with interferon-7 and melphalan for nonresect-able extremity soft tissue sarcomas: a multicenter trial. Journal of Clinical Oncology, 14, 2653–2665.
  • EMAMI, B., Sco'n, C., PEREZ, C. A., ASBELL, S., SWIFT, P., GRIGSBY, P., MONTESANO, A., RUBIN, P., CURRAN, W., DELROWE, J., ARASTU, H., Fu, K., and M OROS, E., 1996, Phase III study of interstitial thermoradiotherapy compared wit interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: a prospectively con-trolled randomized study by the radiation therapy oncology group. International Journal of Radiation Oncology, Biology and Physics, 34, 1097–1104.
  • FALK, R. E., MOFFAT, F. L., LAWLER, M HEINE, J., MAKOWKA, L., and FALK, J. A., 1986, Combination therapy for resectable and unresectable adenocarcinoma of the pancres. Cancer, 57, 685–688.
  • FELDMANN, H. J., MOLLS, M, KRUMPELMANN, S., STUSCHKE, M., and SACK, H., 1993, Deep regional hyperthermia: comparison between the annular phased array and the sigma-60 applicator in the same patients. International Journal of Radiation Oncology, Biology and Physics, 26, 111–116.
  • GAYNOR, J. J., TAN, C. C., CASPER, E. S., COLLLIN, C. F., FRIEDRICH, C., SHIU, M HAJDU, S. M., and BRENNAN, M.F ., 1992, Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: A study of 423 adults. Journal of Clinical Oncology, 10, 1317–1329.
  • GHUSSEN, F., KROGER, I., SMALLEY, R. V., and GROTH, W., 1989, Hyperthermic perfusion with chemotherapy for melanoma of the extremities. World Journal of Surgery, 13, 598–602.
  • GONZALEZ GONZALEZ, D., VAN DuK, J. D. P., BLANK, L. E. C. M., and RUmi(E, P., 1986, Combined treatment with radiation and hyperthermia in metastatic malignant mela-noma. Radiotherapy in Oncology, 6, 105–113.
  • HAFSTRCIM, L., RUDENSTAM, C.-M, BLOMQUIST, E., INGVAR, C., JONSSON, P.-E., LAGERLOF, B., LINDHOLM, C., RINGBORG, U WESTMAN, G., and OSTRUP L., 1991, Regional hyperthermic perfusion with melphalan after surgery for redurrent malignant melanoma of the extremities. Journal of Clinical Oncology, 9, 2091–2094.
  • HAND, J. W., and HIND, A. J., 1986, A review of microwave and RF applicators for localised hyperthermia. Physical techniques in clinical hyperthermia, edited by J. W. Hand and J. R. James (Letchworth: Research Studies Press), pp. 98–148.
  • HAVENGA,K., ENKER, W. E.,N ORSTEIN, J.,M ORIYA, Y., HEALD, R. J., VAN HOUWELINGEN, H. C., and VAN DE VELDE, C. J., 1999, Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. European Journal of Surgical Oncology, 25, 368–374.
  • Hou, B. S., XIONG, Q. B., and Li, D. J., 1989, Thermo-chemo-radiotherapy of esophageal cancer, a preliminary report on 34 cases. Cancer, 64, 1777–1782.
  • IssELs,R.D ., 1995, Soft tissue sarcomas—What is currently being done. European Journal of Surgical Oncology, 21 (suppl), 471–474.
  • I SSELS, R. D., ABDEL-RAHMAN, S., SALAT, C., FALK, M. H., OCHMANN, O., and WILMANNS, W., 1998, Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) followed by surgery and radiation in primary and recurrent high-risk soft tissue sarco-mas (HR-STS) of adults (updated report). Journal of Cancer Research and Clinical Oncology, 124 (suppl.), R105.
  • I SSELS, R. D., BOSSE, D ABDEL-RAHMAN, S., STARCK, M., PANZER, M., JAUCH, K.-J., STIEGLER, H., BERGER, H., SAUER, H., PETER, K., and WILMANNS, W., 1993, Preoperative systemic etoposidelifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study. Cancer Chemotherapy and Pharmacology, 31 (suppL 2), S233—S237.
  • I SSELS, R. D MITTERMOLLER, I., GERL, A., SIMON, W., ORTMAIER, A., DENZLINGER, C., SAUER, H., and WILMANNS, W., 1991, Improvement of local control by regional hyper-thermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients. Journal of Cancer Research and Clinical Oncology, 117, 141–147.
  • I SSELS, R. D PRENNINGER, S. W., NAGELE, A., BOEHM, E., SAUER, H JAUCH, K.-W., DENECKE, H., BERGER, H PETER, K., and WILMANNS, W., 1990, Ifosfamide plus etopo-side combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. Journal of Clinical Oncology, 8, 1818–1829.
  • KAKEHI, M., UEDA, K MUKOHMA, T., HIRAOKA, M., SETO, 0 AKANUMA, A., and NAKATSUGAWA, S., 1990, Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs. International Journal of Hyperthermia, 6, 719–740.
  • KIM, J. H., HAHN, E. W., and AHMED, S. A., 1982, Combination hyperthermia and radiation therapy for malignant melanoma. Cancer, 50, 478–482.
  • KITAMURA, M., SUMIYOSHI, K SONODA, K KITAMURA, K TSUTSUI, S., TOH, Y., KUWANO, H., and SUGIMACHI, K., 1997, The clinical and histopathological contri-buting factors influencing the effectiveness of preoperative hyperthermo-chemo-radio-therapy for the patients with esophageal cancer. Hepato-Gastroenterology, 44, 170–180.
  • K OOPS, H. S., VAGLINI, M., Sum, S., KROON, B. B. R., THOMPSON, J. F., GOHL, J., EGGERMONT, A. M. M., DI FILIPPO, F KREMENTZ, E. T., RUITER, D and LEIEUNE, F. J., 1998, Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. Journal of Clinical Oncology, 16, 2906–2912.
  • LEOPOLD, K. A., HARRELSON, J., PROSNITZ, L., SAMULSKI, T., D EW HIRST, M. W., and OLESON, J. R., 1989, Preoperative hyperthermia and radiation for soft tissue sarcomas: advantage of two vs one hyperthermia treatments per week. International Journal of Radiation Oncology, Biology and Physics, 16, 107–115.
  • LI, D . J., and Hou, B. S., 1987, A preliminary report on the treatment of esophageal cancer by intraluminal microwace hyperthermia and chemotherapy. Cancer Treatment Reports, 71, 1013–1019.
  • MEYER, J. L., KAPP, D. S., FESSENDEN, P., and HAHN, G. H., 1989, Hyperthermic oncology: current biology, physics and clinical results. Pharmacological Therapy, 42, 251–288.
  • OHNO, S., TOMODA, M., TOMISAKI, S., KITAMURA, K., MORI, M., M AEHARA, J., and SUGIMACHI, K., 1997, Improved surgical results after combining preoperative hyper-thermia with chemotherapy and radiotherapy for patients with carcinoma of the rec-tum. Diseases of Colon and Rectum, 40, 401–406.
  • OLESON, J. R., SAMULSKI, T. V., LEOPOLD, K. A., CLEGG, S. T., DEWHIRST, M. W., DODGE, R. K., and GEORGE, S. L., 1993, Sensitivity of hyperthermia trial outcomes to tempera-ture and time: implications for thermal goals of treatment International Journal of Radiation Oncology, Biology and Physics, 25, 289–297.
  • OVERGAARD, J., 1989, The current and potential role of hyperthermia in radiotherapy. International Journal of Radiation Oncology, Biology and Physics, 16, 535–549.
  • OVERGAARD, J., GONZALEZ GONZALES, D HULSHOF, M. C. C.M ARCANGELI, G., DAHL, O., and BENTZEN, S. M., 1995, Randomised trial of hyperthermia as adjuvant to radio-therapy for recurrent or metastatic malignant melanoma. The Lancet, 345, 540–543.
  • PARKS, L. C., and SMITH, G. V., 1983. Systemic hyperthermia by extracorporal induction: techniques and results. Hyperthermia in cancer therapy, edited by F. K. Storm (Boston: GK Hall Medical Publishers), pp. 407–465.
  • PEREZ, C. A., GILLESPIE, B., PAJAK, T., HORBACK, N. B., EmAmi, B., and RUBIN, P., 1989, Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome, a report by the Radiation Therapy Oncology Group. International Journal of Radiation Oncology, Biology and Physics, 16, 551–558.
  • PEREZ, C. A., PAJAK, T., EMAMI, B., HORNBACK, N.B., TUPCHONG, L., and RUBIN, P., 1991, Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. American Journal of Clinical Oncology, 14, 133–141.
  • PROSNITZ, L. R., MAGUIRE, P., ANDERSON, J .M., SCULLY, S. P., HARRELSON, J .M., JONES, E. L., DEWHiRsr, M., SAMULSKI, T. V., POWERS, B. E., ROSNER, G. L., DODGE, R. K., LAYFIELD, L., CLOUGH, R., and BRIZEL, D. M., 1999, The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. International Journal of Radiation Oncology, Biology and Physics, 45, 941–949.
  • RAU, B., WUST, P., HOHENBERGER, P., LOFFEL, J., HONERBEIN, M BELOW, C., GELLERMANN, J SPEIDEL, A., VOGL, T., RIESS, H., FELIX, R., and SCHLAG, P. M., 1998, Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer. A phase II clinical trial. Annals of Surgery, 227, 380–389.
  • RIETBROEK,R. C., SCHILTHUIS, M S., BAKKER, P. J. M., VAN DIJK, J.D.P., POSTMA, A. J., GONZALEZ GONZALEZ, D., BAKKER, A. J., VAN DER VELDEN, J., HELMERHORST, T. J. M., and VEENHOF, C. H. M., 1997, Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer, 79, 935–942.
  • ROBINS, H. I., COHEN, J. D., SCHMITT, C. I., TUTSCH, K. D., FEIERABEND, C., ARZOOMANIAN, R. Z., ALBERTI, D., D'OLEIRE, F., LONGO, W., HEISS, C., RUSHING, D., LOVE, R., and SPRIGGS, D., 1993, A phase I clinical study of carboplatin and 41.8°C whole body hyperthermia in cancer patients. Journal of Clinical Oncology, 11, 1787–1794.
  • ROBINS, H. I., RUSHIN, D., KUTZ, M TUTSCH, K. D., TIGGELAAR, C. L., PAUL, D., SPRIGGS, D., KRAEMER, C., GILLIS, W., FEIERABEND, C ARZOOMANIAN, R. Z., LONGO, W., ALBERTI, D., D'OLEIRE, F., Qu, R. P., WILDING, G., and STEWART, J. A., 1997, Phase I clinical trial of melphalan and 41.8°C whole-body hyperthermia in cancer patients. Journal of Clinical Oncology, 15, 158–164.
  • ROBINS, H. I., WOODS, P. J., SCHMITT, C. L., and COHEN, J. D., 1994, A new technological approach to radiant heat whole body hyperthermia. Cancer Letters, 79, 137–145.
  • ROMANOWSKI, R., SCHOTT, C I SSELS, R., KLINGEBIEL, T., TREUNER, J., JURGENS, H., G ()BEL, U., GOLDSCHMITT-WUTTGE, B., FELDMANN, H., HAAS, R., and HAVERS, W., 1993, Regionale Hyperthermie mit systemischer Chemotherapie bei Kindem und Jugendlichen: Durchfiihrbarkeit und klinische Verlanfe bei 34 intensiv vorbehandelten Patienten mit prognostisch ungiinstigen Tumorerkrankungen Klinische Pädiatrie, 205, 249–256.
  • ROTH, J. A., PUTNAM, J. B., RICH, T. A., and FORASTIERE, A. A., 1997, Cancer of the Esophagus. CancerPrinciples & Practice of Oncology, edited by V. T. Devita, S.Hellman and S. A. Rosenberg (Philadelphia: Lippincott—Raven Publications), pp. 980–1021.
  • SEEGENSCHMIEDT, M H., KLAUTKE, G., SEIDEL, R., and STAUFFER, P.R., 1995, Clinical practice of interstitial thermoradiotherapy. Thermoradiotherapy and Thermo-chemotherapy, Vol. 2, edited by M. H. Seegenschmiedt, P. Fessenden and C. C. Vernon (Berlin: Springer), pp. 207–252.
  • SEEGENSCHMIEDT, M H., MARTUS, P., GRABENBAUER, G. G., FIETKAU, R., ERB, J., IRO, H., WIGAND, M. E., and SAUER, R., 1994, Clinical experience with interstitial thermora-diotherapy for localized head and neck tumors. Turnordiagnostik und Therapie, 15, 63–72.
  • SHERAR, M Liu, F., PINTILIE, M LEVIN, W., HUNT, J., HILL, R., HAND, J., VERNON, C., VAN RHOON, G., VAN DER ZEE, J., GONZALEZ GONZAI F7, D., VAN DIJK, J., WHALEY, J., and MACHIN, D., 1997, Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. International Journal of Radiation Oncology, Biology and Physics, 39, 371–380.
  • SHIBAMOTO, Y., NISHIMURA, Y., and ABE, M., 1996, Intraoperative radiotherapy and hyper-thermia for unresectable pancreatic cancer. Hepato-Gastroenterology, 46, 326–332.
  • SNEED, P. K., STAUFFER, P. R., McD ERMOTT, M. W., DIEDERICH, C. J., LAMBORN, K. R., PRADOS, M. D ., CHANG, S., WEAVER, K. A., SPREY, L., MALEC, M. K., LAMB, S. A., Voss, B., DAVIS, R. L., WARA, W. M., LARSON, D. A., PHILLIPS, T. L., and GUTIN, P. H., 1998, Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost (hyperthermia for glioblastoma multiforme. International Journal of Radiation Oncology, Biology and Physics, 40, 287–295.
  • SUGIMACHI, K KITAMURA, K., BABA, K IKEBE, M., MORITA, M., MATSUDA, H., and KUWANO, H., 1992, Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus—A prospective randomized trial. International Journal of Hyperthermia, 8, 289–295.
  • SUGIMACHI, K., KUWANO, H., IDE, H., TOGE, T., SAKU, M., and OsHiumi, Y., 1994, Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. International Journal of Hyperthermia, 10, 485–493.
  • TAKAHASHI, M., FUJIMOT, S., KOBAYASHI, K MUTOU, T., KURE, M., MASAOKA, H., SHIMANSKAYA, R. B., TAKAI, M ENDOH, F., and OHKUBO, H., 1994, Clinical outcome of intraoperative pelvic hyperthermochemotherapy for patients with Dukes' C rectal cancer. International Journal of Hyperthermia, 10, 749–754.
  • THOMAS, G . M ., 1999, Improved treatment for cervical cancer—concurrent chemotherapy and radiotherapy. New England Journal of Medicine, 340, 1198–1200.
  • UEO,H., and SUGIMACHI, K ., 1990, Preoperative hyperthermochemoradiothermy for patients with esophageal carcinoma or rectal carcinoma. Seminars in Surgical Oncology, 6, 8–13.
  • URANO, M., KURODA, M., and NISHIMURA, Y., 1999, For the clinical application of thermo-chemotherapy given at mild temperatures. International Journal of Hyperthermia, 15, 79–107.
  • VALDAGNI, R., and AMICHETTI, M., 1994, Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to meta-static lymphnodes in stage IV head and neck patients. International Journal of Radiation Oncology, Biology and Physics, 28, 163–169.
  • VALDAGNI, R., AMICHETTI, M., and PANI, G., 1988, Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: a prospective randomized clinical trial. International Journal of Radiation Oncology, Biology and Physics, 15, 13–24.
  • VAN DER ZEE, J., GONZALEZ GONZALEZ, D., VAN RHOON, G. C., VAN DIJK, J. D., VAN PUTTEN, W. L., and HART, A. A., 2000, Comparison of radiotherapy alone with radio-therapy plus hyperthermia in locally advanced pelvic tumours: a prospective, rando-mised, multicentre trial. Dutch Deep Hyperthermia Group. The Lancet, 355, 1119–1125.
  • VERNON, C. C., HAND, J. W., FIELD, S. B., MACHIN, D., WHALEY, J. B., VAN DER ZEE, J., VAN PUTTEN, W. L. J., VAN RHOON, G. C., VAN DIJK, J. D. P., GONZALEZ GONZALEZ, D Liu, F.-F., GOODMAN, P., and SHERAR, M., 1996, Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Journal of Radiation Oncology, Biology and Physics, 35, 731–744.
  • WESSALOWSKI, R KRUCK, H., PAPE, H., KAHN, T., WILLERS, R., and GCIBEL, R., 1998, Hyperthermia for the treatment of patients with malignant germ cell tumors. A phase I/II study in ten children and adolescents with recurrent or refractory tumors. Cancer, 82, 793–800.
  • WIEDEMANN, G. J., D'OLEIRE, F., K NOP, E., ELEETHERIADIS, S., BUCSKY, P., FEDDERSEN, S., KLOUCHE, M., GEISLER, J.,MENTZEL, M., SCHMUCKER, P., FEYERABEND, T., WEISS, C., and WAGNER, T., 1994, Ifosfamide and carboplatin combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Research, 54, 5346–5350.
  • WIEDEMANN, G. J., ROBINS, H. I., GUTSCHE, S., MENTZEL, M., DEEKEN, M., KATSCHINSKI, D. M., ELEFTHERIADIS, S., CRAHE, R., WEISS, C., and WAGNER, T., 1996, Ifosfamide, carboplatin, and etoposide (ICE) combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma. European Journal of Cancer, 32A, 888–891.
  • WUST, P., GELLERMANN, J., HARDER, C., TILLY, W., RAU, B., DINGES, S., SCHLAG, P., BUDACH, V., and FELIX, R., 1998, Rationale for using invasive thermometry for regio-nal hyperthermia of pelvic tumors. International Journal of Radiation Oncology, Biology and Physics, 41, 1129–1137.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.